Search clinical trials for: DATSCAN

Total 33 results

Indonesia University

Recruiting

Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Parkinsonism | Multiple System Atrophy | Multiple System Atrophy, Parkinson Variant

Indonesia
University Hospital, Lille
H. Lundbeck A/S; FeetMe; France Parkinson Association; Vaincre Parkinson

Recruiting

Markers of Disease Progression and Gait Within the Parkinsonian Population (Gait'N'Park)

Parkinson Disease

France
St. Joseph's Hospital and Medical Center, Phoenix

Not yet recruiting

Striatal Dopamine Transporter Density in Post-Traumatic Stress Disorder (PTSD)

Post-traumatic Stress Disorder
Douglas Scharre
Avid Radiopharmaceuticals; Mangurian Foundation

Recruiting

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

Parkinson's Disease | Alzheimer's Disease | Lewy Body Dementia

United States
Mayo Clinic

Enrolling by invitation

DaTSCAN Imaging in Aging and Neurodegenerative Disease

Dementia | Mild Cognitive Impairment | Parkinsonism | REM Sleep Behavior Disorder

United States
Centre Hospitalier Régional d'Orléans

Terminated

Evaluation of Dopaminergic Denervation by DaTSCAN Brain Scintigraphy Using a New Multipurpose CZT System (STARDAT)

Parkinson Disease

France
Central Hospital, Nancy, France

Suspended

Evaluation of the Use of Machine Learning Techniques to Classify Neurodegenerative PARKinsonian Syndromes (Artificial Intelligence) (PARKIA)

DaTSCAN SPECT Scans

France
Ken Marek, MD
Institute for Neurodegenerative Disorders

Completed

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression (PPMI)

Parkinson Disease

United States, Spain, Israel, Norway, Germany, Italy, United Kingdom, France, Austria, Australia, Greece
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Parkinson Disease

United States
GE Healthcare
PPD

Completed

A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

Essential Tremor | Multiple System Atrophy (MSA) | Parkinsonian Syndrome | Parkinson Disease(PD) | Progressive Supranuclear Palsy (PSP)

China
GE Healthcare
PPD

Completed

A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.

Healthy Subjects (HS)

China
Central Hospital, Nancy, France

Completed

DaTSCAN Brain Scintigraphy and Psychotropic Treatments: Influence on Radiotracer Binding (DAPSYFIX)

Parkinson Disease

France
Julie Gurwell

Completed

Idiopathic Parkinson's Progression and Dopamine Transporter SPECT

Parkinson Disease

United States
Central Hospital, Nancy, France

Completed

Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam (VERIDAT)

Parkinson Disease

France
University Hospital, Toulouse

Completed

Dopaminergic Loss and Pain in Parkinson's Disease

Pain | Parkinson's Disease

France
Region Skane
Lund University

Terminated

Diagnostic Imaging for Clear Cell Renal Cell Carcinoma (RCCSCAN)

Clear Cell Renal Cell Carcinoma

Sweden
Molecular NeuroImaging

Completed

Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Alzheimer Disease | Healthy Volunteers | Progressive Supranuclear Palsy

United States
University of Nottingham
Michael J. Fox Foundation for Parkinson's Research; National Institute for...

Unknown

Nigrosomal Iron Imaging in Parkinson's Disease (N3iPD)

Parkinson Disease

United Kingdom
GE Healthcare
Quintiles, Inc.; H2O Clinical LLC

Completed

Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)

Parkinson's Disease | Essential Tremor

United States
University of Minnesota

Completed

DatScan With Prototype Collimator

Parkinson Disease

United States
Navidea Biopharmaceuticals

Withdrawn

A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes

Parkinson's Syndrome

United States
Hospices Civils de Lyon

Unknown

Co-LEsions in Alzheimer Disease and Related Disorders (CLEM)

Lewy Body Disease | Alzheimer's Disease | Cerebrovascular Disease

France
Michael J. Fox Foundation for Parkinson's Research
University of Iowa; Indiana University; Banner Health; Paracelsus Elena Klinik

Completed

Systemic Synuclein Sampling Study (S4) (S4)

Parkinson's Disease

United States, Canada
Assistance Publique - Hôpitaux de Paris
Association Française contre les Myopathies (AFM), Paris; ARS (Association... and other collaborators

Completed

Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls (DOSERAL)

Amyotrophic Lateral Sclerosis

France
University of Chicago

Completed

Parkinsonism in Spinocerebellar Ataxia Type 6

Spinocerebellar Ataxia Type 6

United States
University Hospital, Bordeaux

Completed

Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies (IBVM/DATSCAN)

Dementia With Lewy Bodies

France
Wisconsin Institute for Neurologic and Sleep Disorders...
GE Healthcare; Medical College of Wisconsin; Wisconsin Parkinson Association

Unknown

Validation of DaTscan for Detection of Parkinson Disease Related Disorders

Parkinson Disease | Movement Disorders

United States
GE Healthcare
i3 Statprobe

Completed

A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms

Parkinsonian Syndromes

United States, France
Tel-Aviv Sourasky Medical Center

Unknown

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics

Parkinson Disease

Israel
Tel-Aviv Sourasky Medical Center

Unknown

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Parkinson Disease

Israel
Institute for Neurodegenerative Disorders
GE Healthcare; Pfizer

Completed

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Parkinson Disease | Parkinsonian Syndrome

Spain, Austria, Germany, Italy
University Hospital, Limoges

Completed

Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI) (DatScan)

Lewy Body Dementia

France
GE Healthcare

Completed

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

Vascular Dementia | Lewy Body Dementia | Alzheimer's | Non-DLB Dementia

Germany

Search clinical trials for: DATSCAN

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations